Hyporesponsiveness of the Pituitary to CRH during Slow Wave Sleep Is Not Mimicked by Systemic GHRH

Abstract

During slow wave sleep (SWS) pituitary responsiveness to CRH is reduced. Since GHRH is involved in the promotion of SWS in humans and rats, it was examined whether the blunted CRH-induced ACTH and cortisol release during SWS could be mimicked by systemic GHRH. Young healthy men (n = 7) participated in 4 sleep-endocrine protocols: (A) lights off at 23.00 h, intravenous injection of 50 µg CRH during the first SWS period; (B) lights off at 01.00 h, injection of 100 µg GHRH at 23.00 h, followed by 50 µg CRH at 23.30 h; (C) lights off at 01.00 h, injection of 50 µg CRH at 23.30 h, and (D) lights off at 23.00 h, saline treatment only (= baseline condition). The sleep EEG was recorded during the lights off period and blood samples, collected every 20 min between 22.00 and 07.00 h, were assayed for GH, cortisol and ACTH. There was no significant difference in the sleep-associated GH peak between protocols. Plasma ACTH was significantly higher following CRH administration during wakefulness compared with CRH administration during SWS (protocols B and C vs. A; area under the curve (AUC) 23.00–03.00 h: 9.6 ± 4.8 and 7.3 ± 2.0 vs. 6.1 ± 1.1 ng/ml × min; p < 0.05), while there was no significant difference in plasma ACTH concentration between the baseline condition and protocol A (CRH administration during SWS). Similarly, cortisol was significantly enhanced compared with baseline following CRH during wakefulness only. CRH induced an increase in EEG activity in the sigma frequency range, both when it was administered during wakefulness and SWS, while this effect was reduced by pre-treatment with GHRH. In summary, our data suggest that (1) the blunted CRH-induced release of ACTH and cortisol during SWS is not mimicked by systemic GHRH administration, and (2) CRH enhances sigma EEG activity possibly via modulation of afferent pathways from the median eminence to the thalamus and this effect is reduced by pre-treatment with GHRH.

Ghrelin Stimulates Appetite, Imagination of Food, GH, ACTH, and Cortisol, but does not Affect Leptin in Normal Controls

“…Subsequently, he had a large meal (Weikel et al, 2003). This observation fits with various studies from our laboratory and others showing that repetitive (Steiger and Holsboer, 1997;Weikel et al, 2003) and single (Kerkhofs et al, 1993;Antonijevic et al, 1999a) i.v. bolus injections of neuropeptides modulate human behavior, and in the latter experiments, modulate sleep.…”

State Markers of Depression in Sleep EEG: Dependency on Drug and Gender in Patients Treated with Tianeptine or Paroxetine

“…This could point to the importance of this frequency range as a state marker for depression in general. Interestingly, the EEG power in this frequency range is increased by CRH administration in healthy subjects (Antonijevic et al, 1999b) and rats (Ehlers et al, 1986), supporting an involvement of this peptide in the sleep-EEG changes observed in the course of antidepressant treatment and further pointing to its importance in the pathophysiology of depression (Holsboer, 1999). Earlier studies examining if specific sleep-EEG changes under psychopharmacological treatment are linked to clinical response failed to do so (Mendlewicz et al, 1991;Heiligenstein et al, 1994).…”

Hormones, hormonal agents, and neuropeptides involved in the neuroendocrine regulation of sleep in humans

“…bolus of CRH in young healthy men. 52 Conversely, in sleep-deprived healthy humans, CRH induces higher increases in NREMS if given during the recovery night compared to placebo. 23 The responsiveness of sleep EEG to CRH appears to increase during ageing, since sleep disruption…”